🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the effect of vitamin D supplementation on the neu...
Status
Withdrawn
Location
Laniado Medical Center
Start Date
2017-01-15
Trial ID
NCT03019120
Treatments Being Tested
This phase II trial tests how well the combination of celecoxib with durval...
Status
Recruiting
Location
Grady Health System
Start Date
2026-01-02
Trial ID
NCT07174570
The purpose of this study is to investigate whether tDCS enhances the effec...
Status
Withdrawn
Location
University of Minnesota Comprehensive Epilepsy Center(MINCEP)
Start Date
2020-01-01
Trial ID
NCT02950506
Treatments Being Tested
This phase Ib/II trial tests the safety, side effects, and best dose of que...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-12-01
Trial ID
NCT07667335
This phase I trial studies the safety and side effects of glofitamab plus a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-09
Trial ID
NCT07649304
This phase I trial studies the side effects and best dose of M5A-IL2 immuno...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-05-27
Trial ID
NCT06130826
This phase II trial studies the side effects of an escalated ramp-up of son...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-06-02
Trial ID
NCT06839053
This phase I trial tests the safety, side effects, and best dose of a new d...
Status
Withdrawn
Location
Mayo Clinic in Rochester
Start Date
2024-07-30
Trial ID
NCT05653661
This phase Ib trial tests the safety, side effects, and best dose of the co...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-12-31
Trial ID
NCT06616623
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Active Not Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2023-03-01
Trial ID
NCT05627245